Subchondroplasty® Knee RCT
CompletedNot applicableNCT03112200
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
Brief summary (from the registry)
This is a multi-center, prospective, single-blinded, two-arm study, randomized to include approximately 134 subjects treated with Subchondroplasty (SCP) + Arthroscopy and 67 subjects with arthroscopy alone. The primary objective of this study is to demonstrate superiority of Subchondroplasty with arthroscopy compared to arthroscopy alone for treatment of Bone Marrow Lesions (BMLs) in the knee.
Study details
- Official title
- A Randomized Controlled Trial of the Subchondroplasty® Procedure With Arthroscopy Versus Arthroscopy Alone for Treatment of Bone Marrow Lesions in the Knee
- Conditions
- Interventions
- Procedure: Subchondroplasty with Arthroscopy
- Procedure: Arthroscopy Alone
- Sponsor
- Zimmer Biomet
- Collaborators
- MedNet Solutions; Medical Metrics Diagnostics, Inc
- Start date
- 2017-03-29
- Primary completion
- 2023-08-23
- Sex
- All
- Age range
- from 30 Years to 75 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- Canada, United States
- Total sites listed
- 13
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Candidates must meet ALL of the following: 1. Voluntary signature of the Institutional Review Board/Research Ethics Board approved Informed Consent, 2. Male or female subjects between the ages of 30 to 75 years, 3. Body Mass Index ≤ 40 (BMI=kg/m2), 4. Has experienced pain in study knee for at least 3 months, 5. Kellgren-Lawrence grade 1-3 Osteoarthritis, as reviewed on preoperative XR imaging, in the study knee, 6. BML is confirmed on T2 weighted or Proton Density MR Imaging by presence of white signal, 7. Single BML of tibia, single BML of femur, or adjoining BML's of tibia \& femur, in the same compartment, extending to the articular surface of the joint, 8. Surgical candidate for knee arthroscopy due to mechanical symptoms, meniscus tear, loose body and/or synovitis, 9. Must record a response, at the preoperative study visit, of moderate to extreme pain for any one of the KOOS Pain Scale questions, P2 through P9, 10. Index knee alignment is defined radiographically as one of the following: Neutral, ≤ 6° mechanical varus, or ≤ 6° mechanical valgus, 11. Ligaments in the study knee are stable, 12. The contralateral (non-study) knee is stable and functional, 13. Is refractory to conservative non-surgical management 1. having failed 2 or more of the following: hyaluronic acid injection, corticosteroid injection, NSAIDs, physical therapy, bracing, activity modification, or minimal surgical intervention (e.g., arthroscopy, debridement/chondroplasty, and/or loose body removal) 2. and is ≥ 3 months from the start of treatment, 14. Must be physically and mentally willing and able, in the Investigator's opinion at the time of enrollment, to be compliant with the protocol - including all follow-up visits, survey completion, weight-bearing restrictions, and post-operative rehabilitation. Exclusion Criteria: * Candidates will be excluded if they meet ANY of the following: 1. BML caused by acute trauma less than 3 months prior to enrollment, 2. Clinical and/or radiographic disease diagnosis of the index knee that includes any of the following: 1. Kellgren-Lawrence Grade 4 Osteoarthritis with complete loss of joint space (bone-on-bone) or subchondral bone collapse, 2. Rheumatoid arthritis, or history of septic or reactive arthritis, 3. Gout or a history of gout or pseudogout in the affected knee, 4. Has more than two clinically relevant BMLs in the index knee, 5. Osteochondritis dissecans of the knee with significant bone loss, 6. Collapse of subc…
Canadian sites (1)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03112200